Pages

Friday, March 10, 2006

Joslin researchers reveal mechanisms behind a class of oral agents used to treat type 2 diabetes

Joslin researchers reveal mechanisms behind a class of oral agents used to treat type 2 diabetes

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.